Pfizer "more than 90% prevention rate of corona vaccine under development"
Pfizer vaccine
"In this sense, we look forward to celebrating President-elect Biden and Vice President-elect Camilla Harris and working very closely together with the Lee administration, " WHO Director-General Thewardros-Adhaum Gubrazosus said at the World Health Organization (WHA) that began the day.
"We need to rethink our leadership and build mutual trust and mutual responsibility in order to end this pandemics and address the fundamental inequalities that lie at the base of so many global problems, " he said. Earlier in July, when the Donald Trump administration formalized the U.S. withdrawal from the WHO, Biden immediately expressed his opposition, saying, "On the first day as president, I will rejoin the WHO and restore our leadership on the global stage."
Secretary-General The Ward Ross also called for funding from the WHO, saying there is a very large imbalance between the WHO's annual budget and the expectations of each country. "We welcome all efforts to strengthen the WHO, " he said, adding that there will be a briefing by the committee that evaluated the WHO's response to new coronavirus infections (Corona 19) during the WHO period.
The AFP reported that Taiwan had hoped to participate in the WHA as an observer, but was not invited. Meanwhile, Secretary-General The Ward Ross welcomed the news that the Corona 1919 vaccine being developed by U.S. pharmaceutical company Huiza and Germany's Biogen Tech together has more than 90 percent effect. According to the Associated Press and CNN, Hua analyzed 94 participants in the third phase clinical trial of Corona 19 vaccine development on the 9th (local time) and found that the prevention rate exceeded 90%.
"We welcome the inspiring vaccine news from Huizawa Bioen Tech, " he wrote on Twitter. "We pay tribute to scientists and partners around the world to develop new tools that are safe and efficient to beat Corona 19." "The world is experiencing unprecedented scientific innovation and collaboration to end Pandemics, " he added. According to the WHO, the number of Corona 1919 vaccine candidates in the clinical stage stood at 42, up from 11 in mid-June. Ten of these substances are known to be in phase three clinical trials.
The interim result of the Corona 1919 vaccine being developed by U.S. pharmaceutical company Huiza and Germany's Biogen Tech is more than 90 percent of the prevention rate, is likely to give us hope for an end. Corona, 1928 days later, appeared seven days after the second dose. However, Hua explained, "There are about 44,000 to 44,000 participants who are scheduled to take the clinical test, and the prevention rate can change as the test progresses."
There were no serious patients among those subject to clinical trials. As predicted last month, Huiza will take steps to apply to the U.S. Food and Drug Administration at the end of this month to approve the emergency use of the Corona 1919 vaccine. The FDA requires more than 50 percent preventive effect on the Corona 1919 vaccine currently under development. "It's like seeing light at the end of a tunnel, " said Huiza CEO Albert Bourla.
Today is a day of great development for science and humanity, " he said. "We expect to be able to release additional effects and safety data within weeks."
댓글